Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Hepatol Res ; 49(9): 990-1002, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31364248

ABSTRACT

Although the mortality rate due to hepatocellular carcinoma (HCC) has been gradually decreasing in Japan, approximately 30 000 people died of HCC in 2016. In 2007, the dominant etiology was persistent hepatitis C virus (HCV) infection, which accounted for 65% of total HCC deaths, and 15% of cases were due to chronic hepatitis B virus (HBV) infection. In managing chronic HBV and HCV infection, it is critically important to know the exact number of infected individuals in a particular country, which then assists in evaluating medical and financial needs in the foreseeable future. Therefore, from an epidemiological perspective, we estimated the numbers of HBV and HCV carriers in four categories: (i) undiagnosed carriers; (ii) carriers who were already hospitalized as patients or were receiving outpatient medical attention; (iii) diagnosed carriers who had not consulted any medical facility, or had discontinued consultation; and (iv) newly infected carriers. From these estimates we determined the current HBV and HCV burden and then reviewed the existing countermeasures for their prevention and control in Japan. While continuing the surveillance on the dynamics of hepatitis virus infections linked with preventive measures against hepatitis virus infection, it is crucially important to promote appropriate measures for each of the four groups of hepatitis virus carriers in society.

2.
BMC Res Notes ; 8: 694, 2015 Nov 19.
Article in English | MEDLINE | ID: mdl-26584844

ABSTRACT

BACKGROUND: Rat bite fever is a relatively rare infectious disease due to infection with Streptobacillus moniliformis or Spirillum minus mainly via directs bite by rats, mice, or other rodents. If there is no clear bite history, the diagnosis is difficult or may not be made. CASE PRESENTATION: A 72-year-old Asian female with rheumatoid arthritis was admitted for high grade fever and walking difficulty with severe lumbago. Initially, we suspected lumber compression fracture with deterioration of rheumatoid arthritis, but Gram-negative bacilli were isolated from blood culture during hospitalization. The isolated organism was identified as S. moniliformis by 16S ribosomal ribonucleic acid (rRNA) sequencing. S. moniliformis is well known to be a primary causative organism of rat bite fever, but this patient had no history of rat bite. Had S. moniliformis bacteremia not been detected, she might have been treated for rheumatic exacerbation. CONCLUSION: We emphasize the importance of performing appropriate microbial culture testing for identifying potential infectious diseases. We also conclude that S. moniliformis infection can become established with contaminated vehicle contact alone, not only as a direct result of a bite. We must keep mind that those working in places where rodents breed or are at risk of contact with rats or mice might be at risk for contracting this unusual disease.


Subject(s)
Arthritis, Rheumatoid , Bacteremia/etiology , Fusobacterium Infections/complications , Rat-Bite Fever/complications , Streptobacillus/pathogenicity , Aged , Animals , Bacteremia/diagnosis , Bacteremia/microbiology , Female , Fusobacterium Infections/diagnosis , Fusobacterium Infections/microbiology , Humans , RNA, Ribosomal, 16S , Rat-Bite Fever/diagnosis , Rat-Bite Fever/microbiology
4.
Gan To Kagaku Ryoho ; 36(13): 2599-603, 2009 Dec.
Article in Japanese | MEDLINE | ID: mdl-20009462

ABSTRACT

The present study was undertaken to determine the pharmacoeconomics of switching from sustained-release morphine tablet to matrix type (MT) of transdermal fontanel or sustained-release Oxycodone tablet. Cost-effective analysis was performed using a simulation model along with decision analysis. The analysis was done from the payer's perspective. The cost-effective ratio/patient of transdermal MT fontanel (22, 539 yen)was lower than that of sustained -release Oxycodone tablet (23, 630 yen), although a sensitivity analysis could not indicate that this result was reliable. These results suggest the possibility that transdermal MT fontanel was much less expensive than a sustained-release Oxycodone tablet.


Subject(s)
Analgesics, Opioid/administration & dosage , Analgesics, Opioid/economics , Fentanyl/administration & dosage , Fentanyl/economics , Morphine/administration & dosage , Morphine/economics , Oxycodone/administration & dosage , Oxycodone/economics , Administration, Cutaneous , Cost-Benefit Analysis , Decision Support Techniques , Decision Trees , Delayed-Action Preparations , Humans , Japan , Tablets
5.
Nihon Koshu Eisei Zasshi ; 55(3): 170-6, 2008 Mar.
Article in Japanese | MEDLINE | ID: mdl-18453144

ABSTRACT

PURPOSE: Smoking cessation is one of the most important items for improvement of health in Japan. The Japanese government started a new campaign called the "Health Japan 21" to promote better health of Japanese citizens in the 21st century. The purpose of the present study was to observe the situation of the municipalities throughout Japan regarding implementation of anti-smoking countermeasures and setting of the level of target values to be achieved over the next ten years. METHODS: Mail questionnaire forms were sent to 953 municipalities which had formulated specific local plans for the promotion of health. Of this total, 793 (83.2%) responded to the inquiry. RESULTS: The most commonly implemented countermeasure against smoking was restricting smoking only to limited areas in municipality offices (75%), followed by providing support for stopping smoking (35%), and providing a complete smoke free environment in municipality offices (32.4%). Proportions of local governments putting a ban on smoking on public roads (7.5%), giving publicity to restaurants with smoking restrictions (< 5%) and setting no smoking times in the municipality offices (< 5%) were low. Some 70% of municipalities provided anti-smoking education for school children. Very few local governments took measures such as identifying age at purchasing tobacco, removing vending machines and restricting tobacco advertisement. CONCLUSION: Most municipalities have made much of anti-smoking activities. However, measures for school children were not satisfactorily implemented. The execution rates for anti-smoking activities are low in small-scale municipalities and therefore it is necessary to provide particular support in these cases.


Subject(s)
Health Promotion/methods , Smoking Cessation/methods , Adolescent , Adult , Child , Humans , Japan
6.
Yakugaku Zasshi ; 127(6): 1021-5, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17541254

ABSTRACT

The contents of pharmacist interventions, which were carried out by the ward pharmacists in their routine pharmacy service activities, were sorted and analyzed to evaluate the contributions of pharmacists. In the ward where pharmacists were stationed, there were a total of 196 cases of pharmacist intervention. The prescription was changed in 170 cases, giving a rate of prescription change of 86.7%. The breakdown of the pharmacist intervention was as follows: "efficacy/safety", 106 cases, followed by "dosage regimen" (48 cases) and "compliance" (10 cases). Cost savings achieved during the investigation period were calculated to be 440,639 yen, and cost avoidance was valued at 1,941,847-3,883,695 yen using the Diagnosis Procedure Combination (DPC). The results of the present investigation showed that pharmacists contribute to through not only their pharmacy services, but also through the promotion of proper drug use and risk management, thereby contributing to hospital management through cost savings and avoidance.


Subject(s)
Medication Systems, Hospital , Pharmacists , Pharmacy Service, Hospital/economics , Professional Role , Cost Savings , Drug Prescriptions/economics , Drug Prescriptions/statistics & numerical data , Humans , Medication Systems, Hospital/economics , Medication Systems, Hospital/statistics & numerical data , Risk Management
7.
J Epidemiol ; 15(6): 228-34, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16276032

ABSTRACT

BACKGROUND: The job characteristics scale of job strain, which combines high job demands and low decision latitude based on Karasek's model, has been applied to studies on health care and cardiovascular disease. However, little is known about the long-term stability of this scale with exposure of workers to job. We investigated the 5-year intraindividual variation in job characteristics scores among healthy community workers. METHODS: Subjects of the study were 458 community dwelling persons forming part of the Jichi Medical School Cohort Study at Yamato (currently, Minami-Uonuma city), Niigata prefecture. The Japanese version of the World Health Organization Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (WHO-MONICA) Psychosocial Study Questionnaire was implemented twice (from 1992 through 1995, and in 1999) to measure job demands and decision latitude levels. Intraclass correlation coefficients were computed to evaluate stability of scores of the questionnaire. RESULTS: Intraclass correlation coefficient of the decision latitude scores was 0.629 (95% confidence interval: 0.564-0.686) and that of the job demands scores was 0.551 (0.476-0.617). Subgroup analyses by age, sex, education level, years since first employment, number of co-workers, and job category and status at baseline revealed similar results. In contrast, subjects who experienced position changes within the same enterprise or changed jobs showed lower correlation coefficients of both decision latitude and job demands scores compared to those who experienced no change in job contents. CONCLUSION: The Japanese version of the WHO-MONICA Psychosocial Study Questionnaire showed statistically significant long-term stability and could be to some extent responsive to change in job strain levels.


Subject(s)
Employment/statistics & numerical data , Job Satisfaction , Adult , Aged , Educational Status , Employment/classification , Employment/psychology , Female , Humans , Japan , Male , Middle Aged , Surveys and Questionnaires , Time Factors
8.
J Epidemiol ; 15 Suppl 2: S109-12, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16127221

ABSTRACT

BACKGROUND: In Japan, green tea has been drunk for a long time. Because it can be drunk casually, many people love drinking it. If such green tea has an effect to prevent stomach cancer, it will be a very convenient way to prevent the disease. METHODS: To examine the association between green tea consumption and the risk of stomach cancer, past epidemiologic studies including JACC Study were reviewed. RESULTS: Among eight case-control studies, five showed risk reduction with a statistically significant difference, and two studies showed risk reduction without a statistically significant difference. The remaining study showed the opposite result. Among six prospective studies regarding stomach cancer, no study showed risk reduction with a statistically significant difference. Four of the six studies showed no relation. In terms of study design, prospective studies, which are considered to be more reliable than case-controlled studies, tend to show no risk reduction. The results of case-control studies and prospective studies present considerably different impressions. CONCLUSIONS: Prospective studies showed no inverse association between the consumption of green tea and the risk of stomach cancer.


Subject(s)
Nutritional Status , Stomach Neoplasms/epidemiology , Tea , Beverages , Case-Control Studies , Humans , Japan/epidemiology , Prospective Studies , Risk Assessment , Risk Factors , Stomach Neoplasms/prevention & control
9.
Cancer Lett ; 218(1): 15-20, 2005 Jan 31.
Article in English | MEDLINE | ID: mdl-15639336

ABSTRACT

The cytotoxic effects on HCT 116, Hep G2 and HCT 116/VCR 100-1-1 cell lines of synthetic 4'-O-alkylaloenins (2-17), 4'-O-benzylaloenin (18) and 4'-O-allylaloenin (19) were examined by MTT assay, and compared with that of aloenin (1) isolated from Aloe arborescens Mill. Var. natalensis Berger which showed no marked effect (IC50 value: > 100 microM). The cytotoxic effects of 4'-O-alkylaloenin sulfates (21-29) were also examined on the same cell lines. The introduction of a longer alkyl group at the O-4' position of 1 resulted in a higher cytotoxic action on HCT 116 and Hep G2 cells. Among 4'-O-alkylaloenins 2-17, 4'-O-tetradecylaloenin 14 was the most cytotoxic to both on HCT 116 cells (IC50 value: 5.3+/-2.3 microM) and Hep G2 cells (IC50 value: 4.0+/-0.6 microM). Also among 4'-O-alkylaloenin sulfates 21-29, 4'-O-dodecylaloenin sulfate 29 was the most cytotoxic to both on HCT 116 (IC50 value: 4.8+/-0.2 microM) and Hep G2 cells (IC50 value: 4.0+/-0.5 microM). 4'-O-Alkylaloenins 7-14 and 4'-O-alkylaloenin sulfates 24-29 were also cytotoxic to Hep G2 and HCT 116/VCR 100-1-1 cell lines, which overexpress P-glycoprotein, as well as HCT 116 cell lines which scarcely express it.


Subject(s)
Drug Resistance, Multiple , Glucosides/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Carcinoma, Hepatocellular/pathology , Colorectal Neoplasms , Coloring Agents/chemistry , Drug Resistance, Neoplasm , Drug Screening Assays, Antitumor , Glucosides/chemistry , Humans , Liver Neoplasms/pathology , Sulfates , Tetrazolium Salts/chemistry , Thiazoles/chemistry , Tumor Cells, Cultured
10.
Pharmacoepidemiol Drug Saf ; 14(1): 41-6, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15534857

ABSTRACT

PURPOSE: In Japan, all patients are able to see freely any clinics or hospitals. So clinical data of all patients have been stored at clinics, hospitals and medical institutes respectively. These patients' clinical course data stocks have not been combined with one another. There is no large-scale database, which has been available and has played its role in complementing spontaneous adverse drug reaction (ADR) reporting system. We tried to build an original database using anti-hypertensive drugs' data from Drug Use Investigation conducted for the Japanese Drug Re-examination application by every pharmaceutical manufacturer in conformity with Japanese Pharmaceutical Affairs Law and Related Regulation. METHODS: The 43 565 case data of seven anti-hypertensive drugs (one Ca-antagonist, one alpha-blocker, two beta-blockers, three ACE inhibitors) were kindly offered from seven manufacturers who were members of RAD-AR Council, Japan. After examining the data items and categories, they were standardized into common codes based on Japanese Drug Category Classification (JDCC), International Classification of Diseases 9 (ICD-9) and Japanese Adverse Drug Reaction Terminology (J-ART). As each manufacturer had a different coding method in accordance to manufacturer's own practice of data management, the original forms were divided into several datasets. The data processing and statistical analysis were conducted using Statistical Analysis System (SAS). RESULTS: (1) Technology and know-how to combine data coded by different methods were established for building a database that had never been tried in Japan. (2) The following are the by-products of the study: a) Onset of ADR concentrated in the early stage but onset of some disorders prevailed equally throughout the investigation period. b) Although the number of collected cases of anti-hypertensive drugs was 43 565, total number of administrated anti-hypertensive drugs reached to 70 714 because additional anti-hypertensive drugs were often used with subject drugs. CONCLUSION: There is no large-scale database of patients' clinical course in Japan. However, since the Japanese Drug Re-examination System started in 1979, almost eight million cases of Drug Use Investigation on about 700 drugs have been collected with enormous human power and huge expenditure for Japanese Drug Re-examination application by pharmaceutical manufacturers. New and more appropriate information will be detected by the database, built using Drug Use Investigation data that were collected only for the Japanese Drug Re-examination application.


Subject(s)
Antihypertensive Agents/classification , Databases, Factual/statistics & numerical data , Pilot Projects , Adverse Drug Reaction Reporting Systems/statistics & numerical data , Adverse Drug Reaction Reporting Systems/trends , Computer Systems , Data Collection/methods , Drug Industry/organization & administration , Drug Industry/trends , Government Regulation , Health Services Accessibility , Humans , Japan , Legislation, Drug/trends , Pharmacoepidemiology/trends
SELECTION OF CITATIONS
SEARCH DETAIL
...